NEW research to be presented at this week's International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD) conference in Melbourne highlights the impact of herd immunity from infant pneumococcal conjugate vaccine programs, which have helped protect older adults from invasive pneumococcal disease.
Adults aged 65+ years are eligible for a free Pneumovax 23 vaccine funded under the NIP.
The above article was sent to subscribers in Pharmacy Daily's issue from 17 Apr 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Apr 18
